BenevolentAI
target cation work can we treat by reversing chronic in of the colonic mucosa by targeting pathways in colon epithelial cells and tissue resident immune cells experimental validation identification | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
56 of 74
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Presentation
October 2022
ben target cation work can we treat by reversing chronic in of the colonic mucosa by targeting pathways in colon epithelial cells and tissue resident immune cells experimental validation identification | BenevolentAI
Related slides by other companies
BioAtla
Investor Presentation
May 2023
broad applicability of cab platform across several antibody types | BioAtla
Cytek
Investor Day
June 2022
market forces and needs shaping cell analysis | Cytek
BioAtla
Investor Presentation
August 2022
broad applicability of cab platform across several antibody types | BioAtla
DICE Therapeutics
Investor Presentation
March 2023
the dice approach | DICE Therapeutics
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io